Clinical Genetics
Prenatal & Reproductive Genetics
Screening, diagnosis and counselling across the reproductive pathway.
Scientific context
Understanding the field
Research addresses cell-free DNA screening performance, diagnostic testing in pregnancy, carrier screening and the counselling needs these create.
Prenatal and reproductive genetics evaluates inherited and de novo variation before or during pregnancy. Screening estimates probability, while diagnostic testing addresses a defined clinical question using different evidence and consent pathways.
Central questions
- How accurately do screening tests perform in different populations?
- How should uncertainty and reproductive choices be communicated?
Methodological framework
- Cell-free DNA screening evaluation
- Cytogenomic, molecular and carrier testing
- Decision-support and counselling-outcome research
Relevance
Scientific and clinical value
Evidence-based pathways can improve informed choice, clarify residual risk and distinguish screening results from confirmed diagnoses.
Limits and responsibility
Predictive values depend on prior probability and population. Screening is not diagnostic; decisions should be non-directive, supported by qualified counselling and attentive to autonomy and disability perspectives.
Authoritative resources
Public reference resources
These independent resources are provided for scholarly orientation; inclusion does not imply an institutional partnership. This page does not replace medical advice or diagnosis.